388 related articles for article (PubMed ID: 35970222)
41. Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10-year diabetes cohort study.
Wan EYF; Yu EYT; Chin WY; Barrett JK; Mok AHY; Lau CST; Wang Y; Wong ICK; Chan EWY; Lam CLK
Diabetes Obes Metab; 2020 Oct; 22(10):1777-1788. PubMed ID: 32452623
[TBL] [Abstract][Full Text] [Related]
42. Combined association of lipids and blood pressure in relation to incident cardiovascular disease in the elderly: the cardiovascular health study.
Wong ND; Lopez VA; Roberts CS; Solomon HA; Burke GL; Kuller L; Tracy R; Yanez D; Psaty BM
Am J Hypertens; 2010 Feb; 23(2):161-7. PubMed ID: 19927131
[TBL] [Abstract][Full Text] [Related]
43. Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study.
Hansen MK; Mortensen MB; Warnakula Olesen KK; Thrane PG; Maeng M
Lancet Reg Health Eur; 2024 Jan; 36():100774. PubMed ID: 38019978
[TBL] [Abstract][Full Text] [Related]
44. Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study.
Ting RZ; Yang X; Yu LW; Luk AO; Kong AP; Tong PC; So WY; Chan JC; Ma RC
Cardiovasc Diabetol; 2010 Nov; 9():77. PubMed ID: 21092182
[TBL] [Abstract][Full Text] [Related]
45. Concordance/discordance between serum apolipoprotein B, low density lipoprotein cholesterol and non-high density lipoprotein cholesterol in NATPOL 2011 participants - An epidemiological perspective.
Solnica B; Sniderman AD; Wyszomirski A; Rutkowski M; Chlebus K; Bandosz P; Pencina MJ; Zdrojewski T
Int J Cardiol; 2023 Nov; 390():131150. PubMed ID: 37429441
[TBL] [Abstract][Full Text] [Related]
46. Impact of Blood Lipids on 10-Year Cardiovascular Risk in Individuals Without Dyslipidemia and With Low Risk Factor Burden.
Zhou Z; Ong KL; Whelton SP; Allison MA; Curtis AJ; Blaha MJ; Breslin M; Tonkin A; Magnussen CG; Budoff M; Nelson MR
Mayo Clin Proc; 2022 Oct; 97(10):1883-1893. PubMed ID: 35760597
[TBL] [Abstract][Full Text] [Related]
47. Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.
Nejat A; Mirbolouk M; Mohebi R; Hasheminia M; Tohidi M; Saadat N; Azizi F; Hadaegh F
Clin Biochem; 2014 Sep; 47(13-14):1239-44. PubMed ID: 24657509
[TBL] [Abstract][Full Text] [Related]
48. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
49. Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention.
Sniderman AD; Dufresne L; Pencina KM; Bilgic S; Thanassoulis G; Pencina MJ
Eur Heart J; 2024 May; ():. PubMed ID: 38700053
[TBL] [Abstract][Full Text] [Related]
50. Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events.
Wu F; Jacobs DR; Daniels SR; Kähönen M; Woo JG; Sinaiko AR; Viikari JSA; Bazzano LA; Steinberger J; Urbina EM; Venn AJ; Raitakari OT; Dwyer T; Juonala M; Magnussen CG
JAMA; 2024 Jun; 331(21):1834-1844. PubMed ID: 38607340
[TBL] [Abstract][Full Text] [Related]
51. Low-Density-Lipoprotein Cholesterol and Mortality Outcomes Among Healthy Older Adults: A Post Hoc Analysis of ASPREE Trial.
Zhou Z; Tonkin AM; Curtis AJ; Murray A; Zhu C; Reid CM; Williamson JD; Ryan J; McNeil JJ; Beilin LJ; Ernst ME; Stocks N; Lacaze P; Shah RC; Woods RL; Wolfe R; Gall S; Zoungas S; Orchard SG; Nelson MR
J Gerontol A Biol Sci Med Sci; 2024 Apr; 79(4):. PubMed ID: 38038339
[TBL] [Abstract][Full Text] [Related]
52. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
Wong ND; Chuang J; Zhao Y; Rosenblit PD
J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
[TBL] [Abstract][Full Text] [Related]
53. Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study.
Penson PE; Long DL; Howard G; Toth PP; Muntner P; Howard VJ; Safford MM; Jones SR; Martin SS; Mazidi M; Catapano AL; Banach M
Eur Heart J; 2018 Oct; 39(40):3641-3653. PubMed ID: 30165636
[TBL] [Abstract][Full Text] [Related]
54. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.
Ahmed HM; Miller M; Nasir K; McEvoy JW; Herrington D; Blumenthal RS; Blaha MJ
Am J Epidemiol; 2016 May; 183(10):875-83. PubMed ID: 27189327
[TBL] [Abstract][Full Text] [Related]
55. Serum Low-Density Lipoprotein Cholesterol and Cardiovascular Disease Risk Across Chronic Kidney Disease Stages (Data from 1.9 Million United States Veterans).
Hashemi L; Hsiung JT; Arif Y; Soohoo M; Jackson N; Gosmanova EO; Budoff M; Kovesdy CP; Kalantar-Zadeh K; Streja E
Am J Cardiol; 2022 May; 170():47-55. PubMed ID: 35300833
[TBL] [Abstract][Full Text] [Related]
56. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes.
Sharif S; van der Graaf Y; Nathoe HM; de Valk HW; Visseren FL; Westerink J;
Diabetes Care; 2016 Aug; 39(8):1424-30. PubMed ID: 27222511
[TBL] [Abstract][Full Text] [Related]
57. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
Hadaegh F; Harati H; Ghanbarian A; Azizi F
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147
[TBL] [Abstract][Full Text] [Related]
58. Associations between serum high-density lipoprotein cholesterol levels and cause-specific mortality in a general population of 345 000 men and women aged 20-79 years.
Mørland JG; Magnus P; Vollset SE; Leon DA; Selmer R; Tverdal A
Int J Epidemiol; 2023 Aug; 52(4):1257-1267. PubMed ID: 36779319
[TBL] [Abstract][Full Text] [Related]
59. Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events.
Zhang Y; Pletcher MJ; Vittinghoff E; Clemons AM; Jacobs DR; Allen NB; Alonso A; Bellows BK; Oelsner EC; Zeki Al Hazzouri A; Kazi DS; de Ferranti SD; Moran AE
JAMA Cardiol; 2021 Dec; 6(12):1406-1413. PubMed ID: 34550307
[TBL] [Abstract][Full Text] [Related]
60. The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein Cholesterol.
Al-Sabti H; Al-Hinai AT; Al-Zakwani I; Al-Hashmi K; Al Mahmeed W; Arafah M; Shehab A; Al Tamimi O; Al Awadhi M; Al Herz S; Al Anazi F; Al Nemer K; Metwally O; Alkhadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al Jassim O; Al Hallaq O; Baslaib FOAS; Amin H; Al-Waili K; Al-Rasadi K
Oman Med J; 2022 Mar; 37(2):e367. PubMed ID: 35449790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
